Annual Net Income
-$43.00 M
+$4.50 M+9.48%
September 30, 2024
Summary
- As of February 18, 2025, AVXL annual net profit is -$43.00 million, with the most recent change of +$4.50 million (+9.48%) on September 30, 2024.
- During the last 3 years, AVXL annual net income has fallen by -$5.09 million (-13.43%).
- AVXL annual net income is now -298525.00% below its all-time high of -$14.40 thousand, reached on September 30, 2004.
Performance
AVXL Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Net Income
-$12.11 M
-$491.00 K-4.23%
December 31, 2024
Summary
- As of February 18, 2025, AVXL quarterly net profit is -$12.11 million, with the most recent change of -$491.00 thousand (-4.23%) on December 31, 2024.
- Over the past year, AVXL quarterly net income has dropped by -$491.00 thousand (-4.23%).
- AVXL quarterly net income is now -3477.30% below its all-time high of $358.60 thousand, reached on December 31, 2013.
Performance
AVXL Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Net Income
-$46.49 M
-$3.49 M-8.11%
December 31, 2024
Summary
- As of February 18, 2025, AVXL TTM net profit is -$46.49 million, with the most recent change of -$3.49 million (-8.11%) on December 31, 2024.
- Over the past year, AVXL TTM net income has dropped by -$3.49 million (-8.11%).
- AVXL TTM net income is now -1191976.92% below its all-time high of -$3900.00, reached on December 31, 2004.
Performance
AVXL TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Net Income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
AVXL Net Income Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +9.5% | -4.2% | -8.1% |
| 3 y3 years | -13.4% | -4.2% | -8.1% |
| 5 y5 years | -63.5% | -4.2% | -8.1% |
AVXL Net Income Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -13.4% | +10.4% | -40.5% | +15.3% | -14.5% | +11.8% |
| 5 y | 5-year | -63.6% | +10.4% | -103.0% | +15.3% | -79.3% | +11.8% |
| alltime | all time | <-9999.0% | +10.4% | -3477.3% | +15.3% | <-9999.0% | +11.8% |
Anavex Life Sciences Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | - | -$12.11 M(+4.2%) | -$46.49 M(+8.1%) |
| Sep 2024 | -$43.00 M(-9.5%) | -$11.62 M(-4.9%) | -$43.00 M(+3.5%) |
| Jun 2024 | - | -$12.21 M(+15.8%) | -$41.53 M(+2.3%) |
| Mar 2024 | - | -$10.55 M(+22.3%) | -$40.59 M(-5.9%) |
| Dec 2023 | - | -$8.62 M(-15.0%) | -$43.16 M(-9.2%) |
| Sep 2023 | -$47.51 M(-1.0%) | -$10.15 M(-10.1%) | -$47.51 M(-8.0%) |
| Jun 2023 | - | -$11.28 M(-13.9%) | -$51.65 M(-2.1%) |
| Mar 2023 | - | -$13.11 M(+1.0%) | -$52.74 M(+5.3%) |
| Dec 2022 | - | -$12.97 M(-9.2%) | -$50.07 M(+4.4%) |
| Sep 2022 | -$47.98 M(+26.6%) | -$14.29 M(+15.6%) | -$47.98 M(+5.7%) |
| Jun 2022 | - | -$12.37 M(+18.5%) | -$45.41 M(+5.1%) |
| Mar 2022 | - | -$10.44 M(-4.1%) | -$43.22 M(+5.6%) |
| Dec 2021 | - | -$10.88 M(-7.1%) | -$40.94 M(+8.0%) |
| Sep 2021 | -$37.91 M(+44.2%) | -$11.72 M(+15.1%) | -$37.91 M(+17.9%) |
| Jun 2021 | - | -$10.18 M(+24.8%) | -$32.16 M(+13.0%) |
| Mar 2021 | - | -$8.16 M(+3.8%) | -$28.46 M(+3.3%) |
| Dec 2020 | - | -$7.86 M(+31.7%) | -$27.54 M(+4.8%) |
| Sep 2020 | -$26.28 M(-0.1%) | -$5.97 M(-8.0%) | -$26.28 M(+1.4%) |
| Jun 2020 | - | -$6.49 M(-10.4%) | -$25.92 M(-0.1%) |
| Mar 2020 | - | -$7.24 M(+9.8%) | -$25.96 M(-0.0%) |
| Dec 2019 | - | -$6.59 M(+17.6%) | -$25.97 M(-1.2%) |
| Sep 2019 | -$26.30 M(+52.4%) | -$5.61 M(-14.0%) | -$26.29 M(+0.1%) |
| Jun 2019 | - | -$6.52 M(-10.0%) | -$26.28 M(+16.2%) |
| Mar 2019 | - | -$7.25 M(+4.7%) | -$22.61 M(+12.4%) |
| Dec 2018 | - | -$6.92 M(+23.7%) | -$20.11 M(+16.6%) |
| Sep 2018 | -$17.25 M(+28.2%) | -$5.59 M(+96.3%) | -$17.25 M(+2.6%) |
| Jun 2018 | - | -$2.85 M(-40.0%) | -$16.82 M(-4.3%) |
| Mar 2018 | - | -$4.75 M(+17.1%) | -$17.58 M(+22.3%) |
| Dec 2017 | - | -$4.06 M(-21.3%) | -$14.37 M(+6.8%) |
| Sep 2017 | -$13.46 M(-8.7%) | -$5.15 M(+42.8%) | -$13.46 M(-9.2%) |
| Jun 2017 | - | -$3.61 M(+133.0%) | -$14.82 M(+10.2%) |
| Mar 2017 | - | -$1.55 M(-50.8%) | -$13.45 M(-3.5%) |
| Dec 2016 | - | -$3.15 M(-51.7%) | -$13.93 M(-5.5%) |
| Sep 2016 | -$14.74 M(+21.7%) | -$6.51 M(+190.6%) | -$14.74 M(+8.5%) |
| Jun 2016 | - | -$2.24 M(+10.3%) | -$13.58 M(-12.8%) |
| Mar 2016 | - | -$2.03 M(-48.6%) | -$15.58 M(+2.0%) |
| Dec 2015 | - | -$3.95 M(-26.2%) | -$15.28 M(+26.2%) |
| Sep 2015 | -$12.11 M(+21.5%) | -$5.36 M(+26.3%) | -$12.11 M(-19.6%) |
| Jun 2015 | - | -$4.24 M(+145.8%) | -$15.05 M(+27.3%) |
| Mar 2015 | - | -$1.72 M(+119.3%) | -$11.82 M(+6.4%) |
| Dec 2014 | - | -$786.70 K(-90.5%) | -$11.11 M(+11.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2014 | -$9.97 M(+169.4%) | -$8.30 M(+722.4%) | -$9.97 M(+114.0%) |
| Jun 2014 | - | -$1.01 M(-1.0%) | -$4.66 M(+22.6%) |
| Mar 2014 | - | -$1.02 M(-384.1%) | -$3.80 M(+31.6%) |
| Dec 2013 | - | $358.60 K(-112.0%) | -$2.89 M(-21.9%) |
| Sep 2013 | -$3.70 M(-55.4%) | -$2.99 M(+1867.4%) | -$3.70 M(+166.4%) |
| Jun 2013 | - | -$151.90 K(+43.2%) | -$1.39 M(-76.0%) |
| Mar 2013 | - | -$106.10 K(-76.6%) | -$5.78 M(-12.2%) |
| Dec 2012 | - | -$453.50 K(-33.1%) | -$6.58 M(-20.7%) |
| Sep 2012 | -$8.30 M(+13.6%) | -$677.40 K(-85.1%) | -$8.30 M(-8.2%) |
| Jun 2012 | - | -$4.54 M(+399.1%) | -$9.05 M(+48.7%) |
| Mar 2012 | - | -$910.20 K(-58.1%) | -$6.09 M(-14.9%) |
| Dec 2011 | - | -$2.17 M(+53.0%) | -$7.15 M(+4.2%) |
| Sep 2011 | -$7.31 M(-16.8%) | -$1.42 M(-10.0%) | -$6.86 M(-16.6%) |
| Jun 2011 | - | -$1.58 M(-20.0%) | -$8.23 M(-4.5%) |
| Mar 2011 | - | -$1.97 M(+4.5%) | -$8.62 M(+3.1%) |
| Dec 2010 | - | -$1.89 M(-32.4%) | -$8.36 M(+20.5%) |
| Sep 2010 | -$8.78 M(+59.7%) | -$2.79 M(+42.0%) | -$6.94 M(+13.0%) |
| Jun 2010 | - | -$1.97 M(+14.7%) | -$6.14 M(+11.4%) |
| Mar 2010 | - | -$1.71 M(+266.6%) | -$5.51 M(+9.4%) |
| Dec 2009 | - | -$467.60 K(-76.5%) | -$5.04 M(-8.4%) |
| Sep 2009 | -$5.50 M(+2.8%) | -$1.99 M(+48.6%) | -$5.50 M(-1.5%) |
| Jun 2009 | - | -$1.34 M(+7.9%) | -$5.58 M(-5.8%) |
| Mar 2009 | - | -$1.24 M(+33.8%) | -$5.92 M(+10.4%) |
| Dec 2008 | - | -$928.00 K(-55.2%) | -$5.36 M(-1.1%) |
| Sep 2008 | -$5.35 M(+238.7%) | -$2.07 M(+23.3%) | -$5.42 M(+20.6%) |
| Jun 2008 | - | -$1.68 M(+146.4%) | -$4.50 M(+46.4%) |
| Mar 2008 | - | -$682.00 K(-31.1%) | -$3.07 M(+20.1%) |
| Dec 2007 | - | -$989.30 K(-13.5%) | -$2.56 M(+61.8%) |
| Sep 2007 | -$1.58 M(+6096.1%) | -$1.14 M(+348.9%) | -$1.58 M(+257.4%) |
| Jun 2007 | - | -$254.80 K(+50.7%) | -$442.00 K(+129.1%) |
| Mar 2007 | - | -$169.10 K(+1274.8%) | -$192.90 K(+576.8%) |
| Dec 2006 | - | -$12.30 K(+112.1%) | -$28.50 K(+11.3%) |
| Sep 2006 | -$25.50 K(-72.2%) | -$5800.00(+1.8%) | -$25.60 K(-58.6%) |
| Jun 2006 | - | -$5700.00(+21.3%) | -$61.80 K(-39.3%) |
| Mar 2006 | - | -$4700.00(-50.0%) | -$101.80 K(-28.7%) |
| Dec 2005 | - | -$9400.00(-77.6%) | -$142.80 K(+4.0%) |
| Sep 2005 | -$91.60 K(+536.1%) | -$42.00 K(-8.1%) | -$137.30 K(+44.1%) |
| Jun 2005 | - | -$45.70 K(0.0%) | -$95.30 K(+92.1%) |
| Mar 2005 | - | -$45.70 K(+1071.8%) | -$49.60 K(+1171.8%) |
| Dec 2004 | - | -$3900.00 | -$3900.00 |
| Sep 2004 | -$14.40 K | - | - |
FAQ
- What is Anavex Life Sciences annual net profit?
- What is the all time high annual net income for Anavex Life Sciences?
- What is Anavex Life Sciences annual net income year-on-year change?
- What is Anavex Life Sciences quarterly net profit?
- What is the all time high quarterly net income for Anavex Life Sciences?
- What is Anavex Life Sciences quarterly net income year-on-year change?
- What is Anavex Life Sciences TTM net profit?
- What is the all time high TTM net income for Anavex Life Sciences?
- What is Anavex Life Sciences TTM net income year-on-year change?
What is Anavex Life Sciences annual net profit?
The current annual net income of AVXL is -$43.00 M
What is the all time high annual net income for Anavex Life Sciences?
Anavex Life Sciences all-time high annual net profit is -$14.40 K
What is Anavex Life Sciences annual net income year-on-year change?
Over the past year, AVXL annual net profit has changed by +$4.50 M (+9.48%)
What is Anavex Life Sciences quarterly net profit?
The current quarterly net income of AVXL is -$12.11 M
What is the all time high quarterly net income for Anavex Life Sciences?
Anavex Life Sciences all-time high quarterly net profit is $358.60 K
What is Anavex Life Sciences quarterly net income year-on-year change?
Over the past year, AVXL quarterly net profit has changed by -$491.00 K (-4.23%)
What is Anavex Life Sciences TTM net profit?
The current TTM net income of AVXL is -$46.49 M
What is the all time high TTM net income for Anavex Life Sciences?
Anavex Life Sciences all-time high TTM net profit is -$3900.00
What is Anavex Life Sciences TTM net income year-on-year change?
Over the past year, AVXL TTM net profit has changed by -$3.49 M (-8.11%)